| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528250 | Clinical Therapeutics | 2018 | 12 Pages |
Abstract
This analysis of real-world data found that sevelamer's higher cost relative to calcium acetate was adequately offset by improved survival among patients undergoing dialysis in South Korea. As such, sevelamer offers good value for money, representing a cost-effective alternative to calcium-based binders.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jang-Hee MD, PhD, Hye Min PhD, Hee-Yeon MD, PhD, Ji-Young MD, PhD, Sun-Hee MD, PhD, Chan-Duck MD, PhD, Chul Woo MD, PhD, Dong-Chan MD, PhD, Yong-Lim MD, PhD,